Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)
- Status
- WITHDRAWN
- Phase
- PHASE4
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of Sugammadex in Outpatient Urological Procedures
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs
- Status
- COMPLETED
- Phase
- NA
Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels
- Status
- COMPLETED
- Phase
- PHASE4
Polypharmacy and Clinically Significant Drug Interactions Among HIV-Infected Patients Receiving Antiretroviral Therapy
- Status
- UNKNOWN
- Phase
- N/A
Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of the Tof Cuff for Perioperative Neuromuscular Transmission
- Status
- COMPLETED
- Phase
- N/A